Salvage systemic therapy for advanced gastric and oesophago‐gastric junction adenocarcinoma

Review (17 RCTs; n=5110) found that survival outcomes can be improved by further chemotherapy or biological therapy vs placebo, best supportive care, or no treatment. However, chemotherapy is more associated with unwanted effects vs biological therapy.

Source:

Cochrane Database of Systematic Reviews